Nutrition in oncology: The case of micronutrients (review)

Oncology Reports

Volumn 24, Issue 4, 2010, Pages 815-828

  Ströhle, Alexander ^a   Zänker, Kurt ^b   Hahn, Andreas ^a  

^a LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

3 fatty acids; Cancer cachexia; Malnutrition; Trace elements; Vitamins

Indexed keywords

ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ASCORBIC ACID; BLEOMYCIN; CARBOPLATIN; CISPLATIN; COLECALCIFEROL; COPPER; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; FLUOROURACIL; FOLIC ACID; HYDROXYUREA; IRINOTECAN; IRON; METHOTREXATE; PYRIDOXINE; RETINOID; RETINOL; RETINOL ESTER; SELENIUM; TRACE ELEMENT; VITAMIN D; ZINC;

ANOREXIA; BLEEDING; BONE NECROSIS; BREAST CARCINOMA; CACHEXIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; COLITIS; COLORECTAL CARCINOMA; CYSTITIS; DENTAL CARIES; DIARRHEA; DIET SUPPLEMENTATION; DIETARY REFERENCE INTAKE; DISEASE ASSOCIATION; DYSPHAGIA; ENTERITIS; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS FISTULA; ESOPHAGUS PERFORATION; ESOPHAGUS STENOSIS; FOLIC ACID BLOOD LEVEL; FOOD INTAKE; FOOD PREFERENCE; GINGIVITIS; HEAD AND NECK CARCINOMA; HUMAN; KIDNEY FAILURE; LUNG CARCINOMA; MACRONUTRIENT; MALABSORPTION; MALNUTRITION; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; NUTRIENT SUPPLY; NUTRITIONAL DEFICIENCY; NUTRITIONAL STATUS; PANCREAS CARCINOMA; PATHOGENESIS; PATHOPHYSIOLOGY; PHARYNGITIS; PRIORITY JOURNAL; PROCTITIS; PROSTATE CARCINOMA; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; SMELLING DISORDER; STOMACH CARCINOMA; STOMATITIS; TASTE DISORDER; ULCER; URETER OBSTRUCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WOUND HEALING; XEROSTOMIA; ZINC BLOOD LEVEL;

HUMANS; MALNUTRITION; MICRONUTRIENTS; NEOPLASMS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA;

EID: 77957357552     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000925     Document Type: Review

References (188)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Mackay J, Jemal A, Lee N and Parkin DM: The Cancer Atlas. American Cancer Society, 2006.
3. Ströhle A, Wolters M and Hahn A: Nutrition and colorectal cancer. Med Monatsschr Pharm 30: 25-32, 2007.
4. Ströhle A, Wolters M and Hahn A: Folic acid and colorectal cancer prevention: molecular mechanisms and epidemiological evidence (Review). Int J Oncol 26: 1449-1464, 2005.
5. Du YX, Zhou BS and Wu JM: Lifestyle factors and human lung cancer: an overview of recent advances (Review). Int J Oncol 13: 471-479, 1998.
6. World Cancer Research Fund (WCRF): Food, Nutrition, Physical Activity and the Prevention of Cancer: a Global Perspective. American Institute for Cancer Research, Washington DC, 2007.
7. Platz EA, Willett WC, Colditz GA, Rimm EB, Spiegelman D and Giovannucci E: Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11: 579-588, 2000. (Pubitemid 30636357)
8. Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: progress, potential and promise (Review). Int J Oncol 30: 233-245, 2007.
9. Aziz MH, Kumar R and Ahmad N: Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (Review). Int J Oncol 23: 17-28, 2003.
10. Pathak SK, Sharma RA and Mellon JK: Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review). Int J Oncol 22: 5-13, 2003.
11. Zänker KS: Chemoprevention of cancer for the next millennium-quo vadis? Cancer Lett 143 (Suppl. 1): S7-S11, 1999.
12. Van Cutsem E and Arends J: The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 9 (Suppl. 2): S51-S63, 2005.
13. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G, van Bokhorst-de van der Schueren MA, von Meyenfeldt M; DGEM (German Society for Nutritional Medicine), Zürcher G, Fietkau R, Aulbert E, Frick B, Holm M, Kneba M, Mestrom HJ, Zander A and ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN Guidelines on Enteral Nutrition: non-surgical oncology. Clin Nutr 25: 245-259, 2006.
14. Marín Caro MM, Laviano A and Pichard C: Impact of nutrition on quality of life during cancer. Curr Opin Clin Nutr Metab Care 10: 480-487, 2007. (Pubitemid 46934118)
15. Nitenberg G and Raynard B: Nutritional support of the cancer patient: issues and dilemmas. Crit Rev Oncol Hematol 34: 137-168, 2000. (Pubitemid 30320960)
16. Huhmann MB and August DA: Nutrition support in surgical oncology. Nutr Clin Pract 24: 520-526, 2009.
17. Müller MJ and Bosy-Westphal A: Wie beurteile ich den Ernährungszustand bei kranken Menschen? Aktuel Ernährmed 28: 66-71, 2003.
18. Pirlich M, Schwenk A and Müller MJ: DGEM Guidelines enteral nutrition: nutritional status. Aktuel Ernähr Med 28 (Suppl. 1): S10-S25, 2003. (Pubitemid 36236523)
19. Bozzetti F and SCRINIO Working Group: Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17: 279-284, 2009.
20. Pirlich M, Schutz T, Norman K, et al: The German hospital malnutrition study. Clin Nutr 25: 563-572, 2006.
21. Tong H, Isenring E and Yates P: The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncologypatients. Support Care Cancer 17: 83-90, 2009.
22. Gudny Geirsdottir O and Thorsdottir I: Nutritional status of cancer patients in chemotherapy; dietary intake, nitrogen balance and screening. Food Nutr Res 52: 2008.
23. Sorensen J, Kondrup J, Prokopowicz J, Schiesser M, Krähenbühl L, Meier R, Liberda M and EuroOOPS study group: EuroOOPS: an international, multicentre study to implement nutritional risk screening and evaluate clinical outcome. Clin Nutr 27: 340-349, 2008.
24. Unsal D, Mentes B, Akmansu M, Uner A, Oguz M and Pak Y: Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 29: 183-188, 2006. (Pubitemid 44270961)
25. Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A and Di Palma M: Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18: 433-437, 2010.
26. Guren MG, Tobiassen LB, Trygg KU, Drevon CA and Dueland S: Dietary intake and nutritional indicators are transiently compromised during radiotherapy for rectal cancer. Eur J Clin Nutr 60: 113-119, 2006.
27. Isenring EA, Bauer JD and Capra S: Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc 107: 404-412, 2007.
28. Isenring EA, Capra S and Bauer JD: Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area. Br J Cancer 91: 447-452, 2004. (Pubitemid 39093562)
29. Ravasco P, Monteiro-Grillo I, Marques Vidal P and Camilo ME: Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 27: 659-668, 2005. (Pubitemid 41113766)
30. Ravasco P, Monteiro-Grillo I, Vidal PM and Camilo ME: Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy. J Clin Oncol 23: 1431-1438, 2005. (Pubitemid 46260030)
31. Elango N, Samuel S and Chinnakkannu P: Enzymatic and nonenzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radiotherapy: influence of selenium supplementation. Clin Chim Acta 373: 92-98, 2006.
32. Bosaeus I: Nutritional support in multimodal therapy for cancer cachexia. Support Care Cancer 16: 447-451, 2008.
33. Laviano A, Meguid MM, Inui A, Muscaritoli M and Rossi-Fanelli F: Therapy insight: cancer anorexia-cachexia syndrome-when all you can eat is yourself. Nat Clin Pract Oncol 2: 158-165, 2005.
34. Gordon JN, Green SR and Goggin PM: Cancer cachexia. QJM 98: 779-788, 2005.
35. Andreyev HJ, Norman AR, Oates J and Cunningham D: Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34: 2132-2133, 1998.
36. Ross PJ, Ashley S, Norton A, Priest K, et al: Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer 90: 1905-1911, 2004.
37. Rickard KA, Detamore CM, Coates TD, Grosfeld JL, Weetman RM, White NM, Provisor AJ, Boxer LA, Loghmani ES, Oei TO, Yu PL and Baehner RL: Effect of nutrition staging on treatment delays and outcome in Stage IV neuroblastoma. Cancer 52: 587-598, 1983.
38. Jaakkola K, Lähteenmäki P, Laakso J, Harju E, Tykkä H and Mahlberg K: Treatment with antioxidant and other nutrients in combination with chemotherapy and irradiation in patients with small-cell lung cancer. Anticancer Res 12: 599-606, 1992.
39. Jatoi A, Williams B, Nichols F, Marks R, Aubry MC, Wampfler J, Finke EE and Yang P: Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort. Lung Cancer 49: 77-84, 2005. (Pubitemid 40798096)
40. Jatoi A, Williams BA, Marks R, Nichols FC, Aubry MC, Wampfler J and Yang P: Exploring vitamin and mineral supplementation and purported clinical effects in patients with small cell lung cancer: results from the Mayo Clinic lung cancer cohort. Nutr Cancer 51: 7-12, 2005. (Pubitemid 40365976)
41. DeWys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW and Tormey DC: Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 69: 491-497, 1980.
42. Van Bokorst-de van der Schueren MAE, van Leeuwen PAM, Kuik DJ, et al: The impact of nutritional status on the prognosis of patients with advanced head and neck cancer. Cancer 86: 519-527, 1999.
43. Tian J and Chen JS: Nutritional status and quality of life of the gastric cancer patients in Changle County of China. World J Gastroenterol 11: 1582-1586, 2005.
44. NN: American Institute for Cancer Research: Nutrition of the Cancer Patient. American Institute for Cancer Research, Washington, DC, 2000.
45. NN: National Cancer Institute, U.S. National Institutes of Health: Nutrition in cancer care (PDQ). Health Professional Version. http://www.cancer.gov/cancertopics/pdq/supportivecare/nutrition/ HealthProfessional (Elektronische Publikation, URL am 20.10.2008).
46. Doyle C, Kushi LH, Byers T, Courneya KS, Demark-Wahnefried W, Grant B, McTiernan A, Rock CL, Thompson C, Gansler T, Andrews KS; The 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee; American Cancer Society: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 56: 323-353, 2006.
47. Gogos CA, Ginopoulos P, Salsa B, Apostolidou E, Zoumbos NC and Kalfarentzos F: Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer 82: 395-402, 1998.
48. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ and Fearon KC: Effect of oraleicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 36: 177-184, 2000.
49. Wigmore SJ, Ross JA, Falconer JS, Plester CE, Tisdale MJ, Carter DC and Fearon KC: The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12 (Suppl. 1): S27-S30, 1996.
50. Biondo PD, Brindley DN, Sawyer MB and Field CJ: The potential for treatment with dietary long-chain polyunsaturated n-3 fatty acids during chemotherapy. J Nutr Biochem 19: 787-796, 2008.
51. Federico A, Iodice P, Federico P, Del Rio A, Mellone MC, Catalano G and Federico P: Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr 55: 293-297, 2001.
52. Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Massa E, Mocci M and Serpe R: Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients: assessment of the most important laboratory indexes of cachexia and oxidative stress. J Mol Med 81: 664-673, 2003.
53. Mantovani G, Macciò A, Madeddu C, Mura L, Gramignano G, Lusso MR, Murgia V, Camboni P, Ferreli L, Mocci M and Massa E: The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression. Free Radic Res 37: 213-223, 2003.
54. Mantovani G, Macciò A, Madeddu C, Gramignano G, Lusso MR, Serpe R, Massa E, Astara G and Deiana L: A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev 15: 1030-1034, 2006.
55. Marín Caro MM, Laviano A and Pichard C: Nutritional intervention and quality of life in adult oncology patients. Clin Nutr 26: 289-301, 2007. (Pubitemid 46760478)
56. Mantovani G, Macciò A, Madeddu C, Gramignano G, Serpe R, Massa E, Dessì M, Tanca FM, Sanna E, Deiana L, Panzone F, Contu P and Floris C: Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results. Nutrition 24: 305-313, 2008.
57. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA and Gyllenhaal C: Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 33: 407-418, 2007.
58. Block KI, Koch AC, Mead MN, Tothy PK, Newman RA and Gyllenhaal C: Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials. Int J Cancer 123: 1227-1239, 2008.
59. Norman HA, Butrum RR, Feldman E, Heber D, Nixon D, Picciano MF, Rivlin R, Simopoulos A, Wargovich MJ, Weisburger EK and Zeisel SH: The role of dietary supplements during cancer therapy. J Nutr 133 (Suppl. 11): S3794-S3799, 2003.
60. Prasad KN, Kumar A, Kochupillai V and Cole WC: High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. J Am Coll Nutr 18: 13-25, 1999.
61. Prasad KN, Cole WC, Kumar B and Prasad KC: Scientific rationale for using high-dose multiple micronutrients as an adjunct to standard and experimental cancer therapies. J Am Coll Nutr 20 (Suppl. 5): S450-S463, 2001.
62. Prasad KN, Cole WC, Kumar B and Che Prasad K: Pros and cons of antioxidant use during radiation therapy. Cancer Treat Rev 28: 79-91, 2002.
63. Prasad KN: Antioxidants in cancer care: when and how to use them as an adjunct to standard and experimental therapies. Expert Rev Anticancer Ther 3: 903-915, 2003.
64. Prasad KN: Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity. Integr Cancer Ther 3: 310-322, 2004.
65. D'Andrea GM: Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 55: 319-321, 2005.
66. Lawenda BD, Kelly KM, Ladas EJ, Sagar SM, Vickers A and Blumberg JB: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 100: 773-783, 2008.
67. Van Ommen B, Fairweather-Tait S, Freidig A, Kardinaal A, Scalbert A and Wopereis S: A network biology model of micronutrient related health. Br J Nutr 99 (Suppl. 3): S72-S80, 2008.
68. Laviano A and Meguid MM: Nutritional issues in cancer management. Nutrition 12: 358-371, 1996.
69. DeWys WD: Anorexia as a general effect of cancer. Cancer 43 (Suppl. 5): 2013-2019, 1979.
70. Ravasco P: Aspects of taste and compliance in patients with cancer. Eur J Oncol Nurs 9 (Suppl. 2): S84-S91, 2005.
71. Hutton JL, Baracos VE and Wismer WV: Chemosensory dysfunction is a primary factor in the evolution of declining nutritional status and quality of life in patients with advanced cancer. J Pain Symptom Manage 33: 156-165, 2007.
72. Brisbois TD, Hutton JL, Baracos VE and Wismer WV: Taste and smell abnormalities as an independent cause of failure of food intake in patients with advanced cancer, an argument for the application of sensory science. J Palliat Care 22: 111-114, 2006.
73. Khalid U, Spiro A, Baldwin C, Sharma B, McGough C, Norman AR, Eisen T, O'Brien ME, Cunningham D and Andreyev HJ: Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer 15: 39-46, 2007.
74. Lesko LM: Psychosocial issues in the diagnosis and management of cancer cachexia and anorexia. Nutrition 5: 114-116, 1989.
75. Laviano A, Meguid MM and Rossi-Fanelli F: Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 4: 686-694, 2003.
76. Perboni S and Inui A: Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci 361: 1281-1289, 2006.
77. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A and Meguid MM: Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care 7: 427-434, 2004.
78. Zürcher G: Anorectic syndrome. Z Gastroenterol 40 (Suppl. 1): S71-S75, 2002.
79. Dische S, Warburton MF, Jones D and Lartigau E: The recording of morbidity related to radiotherapy. Radiother Oncol 16: 103-108, 1989.
80. Dische S, Vaeth JM and Meyer JL: Conference summary. Radiation tolerance of normal tissues. Front Radiat Ther Oncol 16: 419-427, 1989.
81. Donaldson SS: Nutritional consequences of radiotherapy. Cancer Res 37: 2407-2413, 1977.
82. Chencharick JD and Mossman KL: Nutritional consequences of the radiotherapy of head and neck cancer. Cancer 51: 811-815, 1983.
83. Mahdavi R, Faramarzi E, Mohammad-Zadeh M, Ghaeammaghami J and Jabbari MV: Consequences of radiotherapy on nutritional status, dietary intake, serum zinc and copper levels in patients with gastrointestinal tract and head and neck cancer. Saudi Med J 28: 435-440, 2007.
84. Grant M and Kravits K: Symptoms and their impact on nutrition. Semin Oncol Nurs 16: 113-121, 2000.
85. O'Brien BE, Kaklamani VG and Benson AB III: The assessment and management of cancer treatment-related diarrhea. Clin Colorectal Cancer 4: 375-381, 2005.
86. Naidu MU, Ramana GV, Rani PU, Mohan IK, Suman A and Roy P: Chemotherapy-induced and/or radiation therapy-induced oral mucositis, complicating the treatment of cancer. Neoplasia 6: 423-431, 2004.
87. Donaldson SS: Nutritional support as an adjunct to radiation therapy. JPEN J Parenter Enteral Nutr 8: 302-310, 1984.
88. Baracos VE: Cancer-associated cachexia and underlying biological mechanisms. Annu Rev Nutr 26: 435-461, 2006.
89. Tisdale MJ: Mechanisms of cancer cachexia. Physiol Rev 89: 381-410, 2009.
90. Tisdale MJ: The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting. J Support Oncol 3: 209-217, 2005.
91. Tisdale MJ: Cachexia in cancer patients. Nat Rev Cancer 2: 862-871, 2002.
92. Argilés JM, Busquets S and López-Soriano FJ: Cytokines in the pathogenesis of cancer cachexia. Curr Opin Clin Nutr Metab Care 6: 401-406, 2003.
93. Norton JA, Stein TP and Brennan MF: Whole body protein synthesis and turnover in normal man and malnourished patients with and without known cancer. Ann Surg 194: 123-128, 1981.
94. Lundholm K, Edström S, Ekman L, Karlberg I and Scherstén T: Metabolism in peripheral tissues in cancer patients. Cancer Treat Rep 65 (Suppl. 5): S79-S83, 1981.
95. Smith HJ, Wyke SM and Tisdale MJ: Role of protein kinase C and NF-kappaB in proteolysis-inducing factor-induced proteasome expression in C(2)C(12) myotubes. Br J Cancer 90: 1850-1857, 2004.
96. Whitehouse AS and Tisdale MJ: Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB. Br J Cancer 89: 1116-1122, 2003.
97. Wyke SM, Khal J and Tisdale MJ: Signalling pathways in the induction of proteasome expression by proteolysis-inducing factor in murine myotubes. Cell Signal 17: 67-75, 2005.
98. Wyke SM and Tisdale MJ: NF-kappaB mediates proteolysis-inducing factor induced protein degradation and expression of the ubiquitin-proteasome system in skeletal muscle. Br J Cancer 92: 711-721, 2005.
99. Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A and Lundholm KG: Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care, correlations with food intake, metabolism, exercise capacity, and hormones. Cancer 103: 2189-2198, 2005.
100. Shaw JH and Wolfe RR: Fatty acid and glycerol kinetics in septic patients and in patients with gastrointestinal cancer. The response to glucose infusion and parenteral feeding. Ann Surg 205: 368-376, 1987.
101. Legaspi A, Jeevanandam M, Starnes HF Jr and Brennan MF: Whole body lipid and energy metabolism in the cancer patient. Metabolism 36: 958-963, 1987.
102. Russell ST and Tisdale MJ: The role of glucocorticoids in the induction of zinc-alpha2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 92: 876-881, 2005.
103. Hirai K, Hussey HJ, Barber MD, Price SA and Tisdale MJ: Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58: 2359-2365, 1998.
104. Fearon KC, Voss AC, Hustead DS and Cancer Cachexia Study Group: Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83: 1345-1350, 2006.
105. Uomo G, Gallucci F and Rabitti PG: Anorexia-cachexia syndrome in pancreatic cancer: recent development in research and management. JOP 7: 157-162, 2006.
106. Barber MD, Ross JA and Fearon KC: Disordered metabolic response with cancer and its management. World J Surg 24: 681-689, 2000.
107. Argilés JM, Costelli P, Carbó N, Pallarés-Trujillo J and López-Soriano FJ: Tumour growth and nitrogen metabolism in the host (Review). Int J Oncol 14: 479-486, 1999.
108. Tubiana M, Attié E, Flamant R, et al: Prognostic factors in 454 cases of Hodgkin's disease. Cancer Res 31: 1801-1810, 1971.
109. Swenerton KD, Legha SS, Smith T, et al: Prognostic factors in metastaticbreast cancer treated with combination chemotherapy. Cancer Res 39: 1552-1562, 1979.
110. Persson C and Glimelius B: The relevance of weight loss for survival and quality of life in patients with advanced gastrointestinal cancer treated with palliative chemotherapy. Anticancer Res 22: 3661-3668, 2002.
111. Stanley K: Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst 65: 25-32, 1980.
112. Pedersen H, Hansen HS, Cederqvist C and Lober J: The prognostic significance of weight loss and its integration in stage-grouping of oesophageal cancer. Acta Chir Scand 148: 363-366, 1982.
113. Fein R, Kelsen DP, Geller N, et al: Adenocarcinoma of the esophagus and gastroesophageal junction. Prognostic factors and results of therapy. Cancer 15: 2512-2518, 1985.
114. Edington J, Winter PD, Cole SJ, et al: Outcomes of under-nutrition in the community with cancer or cardiovascular disease. Proc Nutr Soc 58: 655-661, 1999.
115. Bosaeus I, Daneryd P and Lundholm K: Dietary intake, resting energy expenditure, weight loss and survival in cancer patients. J Nutr 132: S3465-S3466, 2002.
116. Bosaeus IG, Ellegard L, Malmros V, et al: Body composition, gender, and survival in advanced cancer. Clin Nutr (Suppl. 2): 111, 2007.
117. Gupta D, Lammersfeld CA, Burrows JL, et al: Bioelectric impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr 80: 1634-1638, 2004.
118. Mitry E, Douillard JY, Van Cutsem E, et al: Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trials. Ann Oncol 15: 1013-1017, 2004.
119. Lee GJ, Chung HW, Lee KH and Ahn HS: Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J Korean Med Sci 20: 267-272, 2005.
120. Skrzydlewska E, Sulkowski S, Koda M, Zalewski B, Kanczuga-Koda L and Sulkowska M: Lipid peroxidation and antioxidant status in colorectal cancer. World J Gastroenterol 11: 403-406, 2005.
121. Yeh CC, Hou MF, Tsai SM, Lin SK, Hsiao JK, Huang JC, Wang LH, Wu SH, Hou LA, Ma H and Tsai LY: Superoxide anion radical, lipid peroxides and antioxidant status in the blood of patients with breast cancer. Clin Chim Acta 361: 104-111, 2005.
122. Trump DL, Chadha MK, Sunga AY, Fakih MG, Ashraf U, Silliman CG, Hollis BW, Nesline MK, Tian L, Tan W and Johnson CS: Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int, April 4, 2009. (Epub ahead of print).
123. Fakih MG, Trump DL, Johnson CS, Tian L, Muindi J and Sunga AY: Chemotherapy is linked to severe vitamin D deficiency in patients with colorectal cancer. Int J Colorectal Dis 24: 219-224, 2009.
124. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D and Hershman DL: High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 27: 2151-2156, 2009.
125. Palan PR, Woodall AL, Anderson PS and Mikhail MS: Alpha-tocopherol and alpha-tocopheryl quinone levels in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol 190: 1407-1410, 2004.
126. Ray G and Husain SA: Role of lipids, lipoproteins and vitamins in women with breast cancer. Clin Biochem 34: 71-76, 2001.
127. Lin CC and Yin MC: B vitamins deficiency and decreased anti-oxidative state in patients with liver cancer. Eur J Nutr 46: 293-299, 2007.
128. Tsao SM, Yin MC and Liu WH: Oxidant stress and B vitamins status in patients with non-small cell lung cancer. Nutr Cancer 59: 8-13, 2007.
129. Anthony HM and Schorah CJ: Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte-related host resistance. Br J Cancer 46: 354-367, 1982.
130. Fin O, Mathieu E and Thomas M: Scurvy in patients with cancer. BMJ 316: 1661-1662, 1998.
131. Zuo XL, Chen JM, Zhou X, Li XZ and Mei GY: Levels of selenium, zinc, copper, and antioxidant enzyme activity in patients with leukemia. Biol Trace Elem Res 114: 41-53, 2006.
132. Büntzel J, Bruns F, Glatzel M, Garayev A, Mücke R, Kisters K, Schäfer U, Schönekaes K and Micke O: Zinc concentrations in serum during head and neck cancer progression. Anticancer Res 27: 1941-1943, 2007.
133. Stefanini M: Cutaneous bleeding related to zinc deficiency in two cases of advanced cancer. Cancer 86: 866-870, 1999.
134. Mantovani G, Macciò A, Madeddu C, Mura L, Massa E, Gramignano G, Lusso MR, Murgia V, Camboni P and Ferreli L: Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment. J Cell Mol Med 6: 570-582, 2002.
135. Chang D, Wang F, Zhao YS and Pan HZ: Evaluation of oxidative stress in colorectal cancer patients. Biomed Environ Sci 21: 286-289, 2008.
136. Leung EY, Crozier JE, Talwar D, O'Reilly DS, McKee RF, Horgan PG and McMillan DC: Vitamin antioxidants, lipid peroxidation, tumour stage, the systemic inflammatory response and survival in patients with colorectal cancer. Int J Cancer 123: 2460-2464, 2008.
137. Clemens MR, Müller-Ladner CI and Gey KF: Vitamins during high dose chemo- and radiotherapy. Z Ernährungswiss 31: 110-120, 1992.
138. Clemens MR, Ladner C, Ehninger G, Einsele H, Renn W, Bühler E, Waller HD and Gey KF: Plasma vitamin E and beta-carotene concentrations during radiochemotherapy preceding bone marrow transplantation. Am J Clin Nutr 51: 216-219, 1990.
139. Kennedy DD, Ladas EJ, Rheingold SR, Blumberg J and Kelly KM: Antioxidant status decreases in children with acute lymphoblastic leukemia during the first six months of chemotherapy treatment. Pediatr Blood Cancer 44: 378-385, 2005.
140. Malvy DJ, Burtschy B, Arnaud J, Sommelet D, Leverger G, Dostalova L, Drucker J and Amédée-Manesme O: Serum beta-carotene and antioxidant micronutrients in children with cancer. The 'Cancer in Children and Antioxidant Micronutrients' French Study Group. Int J Epidemiol 22: 761-771, 1993.
141. Lotti T, Rodofili C, Benci M and Menchin G: Wound-healing problems associated with cancers. J Wound Care 7: 81-84, 1998.
142. Dormand EL, Banwell PE and Goodacre TE: Radiotherapy and wound healing. Int Wound J 2: 112-127, 2005.
143. Bryan J and Calvaresi E: Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife. J Nutr Health Aging 8: 226-232, 2004.
144. Kamphuis MH, Geerlings MI, Grobbee DE and Kromhout D: Dietary intake of B(6-9-12) vitamins, serum homocysteine levels and their association with depressive symptoms: the Zutphen Elderly Study. Eur J Clin Nutr 62: 939-945, 2008.
145. Ströhle A and Hahn A: Vitamin C and immune function. Med Monatsschr Pharm 32: 49-54, 2009.
146. Ströhle A and Hahn A: Bedeutung von Mikronährstoffen für die Immunkomeptenz. Präventive und therapeutische Aspekte. MMW Fortschr Med Originalien III: 133-141, 2009.
147. Biesalski H-K: Mikronährstoffsupplemente bei onkologischen Patienten. Onkologe 14: 45-57, 2008.
148. Hahn A, Ströhle A and Biesalski HK: Mikronährstoff-supplemente. In: Ernährungsmedizin. Biesalski HK, Bischoff S and Puchstein S (eds). Thieme, Stuttgart, 2010.
149. Hutton JL, Martin L, Field CJ, Wismer WV, Bruera ED, Watanabe SM and Baracos VE: Dietary patterns in patients with advanced cancer: implications for anorexia-cachexia therapy. Am J Clin Nutr 84: 1163-1170, 2006.
150. Zürcher G, Gola U and Biesalski H-K: Antioxidanzien bei Krebs. Schweizer Zeitschrift für Ernährungsmedizin 4: 17-19, 2007.
151. Labriola D and Livingston R: Possible interactions between dietary antioxidants and chemotherapy. Oncology 13: 1003-1008, 1999.
152. Salganik RI, Albright CD, Rodgers J, Kim J, Zeisel SH, Sivashinskiy MS and Van Dyke TA: Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. Carcinogenesis 21: 909-914, 2000.
153. Kucuk O and Ottery FD: Dietary supplements during cancer treatment. Oncol Issues 17: 22-30, 2002.
154. Michaud LB, Karpinski JP, Jones KL and Espirito J: Dietary supplements in patients with cancer: risks and key concepts, part 2. Am J Health Syst Pharm 64: 467-480, 2007.
155. Michaud LB, Karpinski JP, Jones KL and Espirito J: Dietary supplements in patients with cancer: risks and key concepts, part 1. Am J Health Syst Pharm 64: 369-381, 2007.
156. Simone CB II, Simone NL, Simone V and Simone CB: Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. Altern Ther Health Med 13: 22-28, 2007. (Pubitemid 46110631)
157. Simone CB II, Simone NL, Simone V and Simone CB: Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. Altern Ther Health Med 13: 40-47, 2007. (Pubitemid 46427632)
158. Greenlee H, Hershman DL and Jacobson JS: Use of antioxidant supplements during breast cancer treatment: a comprehensive review. Breast Cancer Res Treat 115: 437-452, 2009.
159. Hardy ML: Dietary supplement use in cancer care: help or harm. Hematol Oncol Clin North Am 22: 581-617, 2008.
160. Brown JK, Byers T, Doyle C, Coumeya KS, Demark-Wahnefried W, Kushi LH, McTieman A, Rock CL, Aziz N, Bloch AS, Eldridge B, Hamilton K, Katzin C, Koonce A, Main J, Mobley C, Morra ME, Pierce MS, Sawyer KA and American Cancer Society: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 53: 268-291, 2003.
161. Gross RL: The effect of ascorbate on wound healing. Int Ophthalmol Clin 40: 51-57, 2000.
162. Borkow G, Gabbay J and Zatcoff RC: Could chronic wounds not heal due to too low local copper levels? Med Hypotheses 70: 610-613, 2008.
163. Demling RH: Nutrition, anabolism, and the wound healing process: an overview. Eplasty 9: e9, 2009.
164. Kurrmann S and Burrowes JD: Nutrition of non-critically ill wound patients, special supplements. Aktuel Ernährungsmed 34: 269-277, 2009.
165. Hausinnger RP: Fell/alpha-ketoglutarate-dependent hydroxylases and related enzymes. Crit Rev Biochem Mol Biol 39: 21-68, 2004.
166. Padh H: Cellular functions of ascorbic acid. Biochem Cell Biol 68: 1166-1173, 1990.
167. Shukla SP: Plasma and urinary ascorbic acid levels in the postoperative period. Experientia 25: 704, 1969.
168. Irvin TT, Chattopadhyay DK and Smythe A: Ascorbic acid requirements in postoperative patients. Surg Gynecol Obstet 147: 49-55, 1978.
169. Taylor TV, Rimmer S, Day B, Butcher J and Dymock IW: Ascorbic acid supplementation in the treatment of pressure-sores. Lancet 2: 544-546, 1974.
170. Mantovani G, Madeddu C, Macciò A, Gramignano G, Lusso MR, Massa E, Astara G and Serpe R: Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 13: 1651-1659, 2004.
171. Laviano A, Meguid MM, Preziosa I and Rossi Fanelli F: Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 10: 449-456, 2007.
172. Bonetto A, Penna F, Muscaritoli M, Minero VG, Rossi Fanelli F, Baccino FM and Costelli P: Are antioxidants useful for treating skeletal muscle atrophy? Free Radic Biol Med 47: 906-916, 2009.
173. Colomer R, Moreno-Nogueira JM, García-Luna PP, García-Peris P, García-de-Lorenzo A, Zarazaga A, Quecedo L, del Llano J, Usán L and Casimiro C: N-3 fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr 97: 823-831, 2007.
174. Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, Goedhart A, Lundholm K, Nitenberg G and Stratton RJ: Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 28: 5-23, 2006.
175. Muscaritoli M, Costelli P, Aversa Z, Bonetto A, Baccino FM and Rossi Fanelli F: New strategies to overcome cancer cachexia: from molecular mechanisms to the 'Parallel Pathway'. Asia Pac J Clin Nutr 17 (Suppl. 1): 387-390, 2008.
176. Sinclair HM: Essential fatty acids: an historical perspective. Biochem Soc Trans 18: 756-761, 1990.
177. Pawlosky RJ, Hibbeln JR, Novotny JA, et al: Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 42: 1257-1265, 2001.
178. Brenna JT: Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr Opin Clin Nutr Metab Care 5: 127-132, 2002.
179. Wallis JG, Watts JL and Browse J: Polyunsaturated fatty acid synthesis: what will they think of next? Trends Biochem Sci 27: 467, 2002.
180. Stehr SN and Heller AR: Omega-3 fatty acid effects on biochemical indices following cancer surgery. Clin Chim Acta 373: 1-8, 2006.
181. Li YP and Reid MB: NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol 279: R1165-R1170, 2000.
182. Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N: Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 27: 3757-3763, 2009.
183. Ng K, Wolpin BM, Meyerhardt JA, Wu K, Chan AT, Hollis BW, Giovannucci EL, Stampfer MJ, Willett WC and Fuchs CS: Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer 101: 916-923, 2009.
184. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL and Fuchs CS: Circulating 25-hydroxy-vitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26: 2984-2991, 2008.
185. Molassiotis A, Fernandez-Ortega P, Pud D, Ozden G, Platin N, Hummerston S, Scott JA, Panteli V, Gudmundsdottir G, Selvekerova S, Patiraki E and Kearney N: Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med 13: 251-257, 2005. (Pubitemid 43024870)
186. Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, Margulies A, Browall M, Magri M, Selvekerova S, Madsen E, Milovics L, Bruyns I, Gudmundsdottir G, Hummerston S, Ahmad AM, Platin N, Kearney N and Patiraki E: Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 16: 655-663, 2005. (Pubitemid 40613334)
187. Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, Hathcock J, Giovannucci E and Willett WC: Benefit-risk assessment of vitamin D supplementation. Osteoporos Int, December 3, 2009 (Epub ahead of print).
188. Cantor I: Shedding light on vitamin D and integrative oncology. Integr Cancer Ther 7: 81-89, 2008.